Inside the research

American Healthcare REIT, Inc.

AHR Research profile · latest available data

Price overview

$52.02

▼ -0.29 (-0.6%)

52w hi$57.72
52w lo$39.57
Vol2.72M
As of25 Sep 2026

The Verdict

Hold

Our score +0.13

Short+0.29
Medium+0.06
Long-0.06

computed 2026-09-27

Key fundamentals

American Healthcare REIT, Inc.

Real Estate · REIT - Healthcare Facilities

Market cap$11.34B
Enterprise value$12.80B
Trailing P/E76.50x
Forward P/E52.55x
EV / EBITDA28.60x
P / S (ttm)4.53x
Profit margin4.8%
Return on equity4.0%
Revenue growth+24.7%
Earnings growth+157.5%
Debt / equity41.89

Layer Breakdown

LayerRawContribution
Fundamental+0.22
Sector-0.04
Technical+0.16
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements. American Healthcare REIT, Inc. is based in Irvine, United States.

United States · www.americanhealthcarereit.com

Risk Metrics

Beta vs SPX0.38
Corr SPX0.23
Annual vol26.6%
Annual ret+38.8%
Sharpe1.46
Max DD-14.1%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$57.92
High / Low$63.00 / $54.00
Median$58.00
Analysts13
Strong Buy5
Buy7
Hold1
Sell0
Strong Sell0

Recent rating actions

2026-03-13Truist Securities→ Buy
2026-03-11Scotiabank→ Sector Outperform
2026-03-02Citigroup→ Neutral
2026-02-05Citizens→ Market Outperform
2026-01-29BMO Capital→ Outperform
2026-01-20Truist Securities→ Buy

Material Events

DateEvent8-K
2026-08-12Other Material Eventread
2026-08-10Material Agreementread
2026-08-06Earnings Release, Reg FD Disclosure…read
2026-07-22Officer / Director Change, Reg FD Disclosure…read
2026-06-25Shareholder Voteread
2026-06-18Reg FD Disclosure, Other Material Event…read
2026-05-28Other Material Event, Exhibitsread
2026-05-22Other Material Event, Exhibitsread
2026-05-07Earnings Release, Reg FD Disclosure…read
2026-04-07Material Agreement, Material Obligation…read
2026-03-18Reg FD Disclosure, Other Material Event…read
2026-02-27Material Agreement, Exhibitsread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share99.2%
HHI3,052 (concentrated)

Top Holders

HolderValueShares
State Street Corp$473.97M9.05M
Fidelity / FMR LLC$238.23M4.57M
Citadel Advisors$112.03M2.15M
Millennium Management$103.89M1.99M
Capital Research / Capital World$71.08M1.36M
AQR Capital Management$8.19M159.18K
T. Rowe Price Group$135.94K2.61M

As of 2026-06-30

Dividends

Yield (TTM)1.44%
$ / share (TTM)$0.75
5y CAGR—

Annual dividend per share

2024$1.00
2025$1.00
2026$0.25

SEC Filings

DateFormDoc
2026-08-128-Kview
2026-08-11424B5view
2026-08-108-Kview
2026-08-10424B5view
2026-08-0710-Qview
2026-08-068-Kview
2026-07-224view
2026-07-224view
2026-07-224view
2026-07-228-Kview
2026-06-294view
2026-06-264view
2026-06-264view
2026-06-264view
2026-06-264view

The Long Run

FY 2015–2025 · 11 years

LineLatestCAGRTrend
Revenue$1.67B+128.3%
Operating income$306.83M+8.9%
Net income-$71.47M—
Cash from ops$98.53M+29.6%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$52.30$52.48$51.90$52.022.72M
Sep 24$52.09$52.84$51.83$52.312.46M
Sep 23$51.51$52.30$51.31$51.703.87M
Sep 22$52.25$52.33$51.61$51.692.77M
Sep 21$53.15$53.15$52.11$52.302.66M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →